Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525-36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit

Affiliations

¹ Division of Surgery and Interventional Science, University College London, London, UK. Electronic address: s.abeysiri@ucl.ac.uk.
² Division of Surgery and Interventional Science, University College London, London, UK.

Comment

Sandaruwani Abeysiri et al. Eur Urol. 2019 Feb.

. 2019 Feb;75(2):e36.

doi: 10.1016/j.eururo.2018.09.014. Epub 2018 Sep 27.

¹ Division of Surgery and Interventional Science, University College London, London, UK. Electronic address: s.abeysiri@ucl.ac.uk.
² Division of Surgery and Interventional Science, University College London, London, UK.

No abstract available

Comment on

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Parekh DJ, et al. Lancet. 2018 Jun 23;391(10139):2525-2536. doi: 10.1016/S0140-6736(18)30996-6. Lancet. 2018. PMID: 29976469 Clinical Trial.